TY - JOUR
T1 - Correlates of kidney stone disease differ by race in a multi-ethnic middle-aged population
T2 - The ARIC study
AU - Akoudad, Saloua
AU - Szklo, Moyses
AU - McAdams, Mara A.
AU - Fulop, Tibor
AU - Anderson, Cheryl A.M.
AU - Coresh, Josef
AU - Köttgen, Anna
N1 - Funding Information:
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute contracts N01-HC-55015 , N01-HC-55016 , N01-HC-55018 , N01-HC-55019 , N01-HC-55020 , N01-HC-55021 and N01-HC-55022 . The authors thank the staff and participants of the ARIC study for their important contributions. We thank Dr. Gary Curhan for helpful discussions and critical review of the manuscript. Some of the data in this abstract has been presented at the annual meeting of the American Society of Nephrology in November of 2009.
PY - 2010/11
Y1 - 2010/11
N2 - Objective: To identify correlates of kidney stone disease in white and African American men and women in a population-based longitudinal study starting in four US communities, and to assess differences in correlates across racial groups. Methods: Between 1993 and 1995, 12,161 middle-aged participants of the ARIC Study provided information on history of kidney stone disease. Information on incident kidney stone-related hospitalizations was obtained from ICD codes on hospital discharge records. Results: Kidney stone disease was reported by 12.0% of men and 4.8% of women. After multivariable adjustment, prevalent kidney stone disease was significantly (p< 0.05) associated with male gender (PR. = 2.50), increased serum triglycerides (PR. = 1.07 per SD increase), diabetes (PR. = 1.27), gallstone disease (PR. = 1.54), white race (PR. = 1.67), and region of residence. Male gender (HR. = 1.70), diabetes (HR. = 1.98), and hypertension (HR. = 1.69) were significantly associated (p< 0.05) with incident kidney stone-related hospitalizations (n= 94). Race-stratified analyses showed stronger associations of prevalent kidney stone disease with increased triglycerides, older age, and gallstone disease in African Americans compared to whites, whereas male gender showed stronger association in whites (all p-interaction < 0.05). Conclusion: We identified novel correlates of kidney stone disease (triglycerides, gallstone disease) and risk factor interactions by race (age, male gender, triglycerides, gallstone disease).
AB - Objective: To identify correlates of kidney stone disease in white and African American men and women in a population-based longitudinal study starting in four US communities, and to assess differences in correlates across racial groups. Methods: Between 1993 and 1995, 12,161 middle-aged participants of the ARIC Study provided information on history of kidney stone disease. Information on incident kidney stone-related hospitalizations was obtained from ICD codes on hospital discharge records. Results: Kidney stone disease was reported by 12.0% of men and 4.8% of women. After multivariable adjustment, prevalent kidney stone disease was significantly (p< 0.05) associated with male gender (PR. = 2.50), increased serum triglycerides (PR. = 1.07 per SD increase), diabetes (PR. = 1.27), gallstone disease (PR. = 1.54), white race (PR. = 1.67), and region of residence. Male gender (HR. = 1.70), diabetes (HR. = 1.98), and hypertension (HR. = 1.69) were significantly associated (p< 0.05) with incident kidney stone-related hospitalizations (n= 94). Race-stratified analyses showed stronger associations of prevalent kidney stone disease with increased triglycerides, older age, and gallstone disease in African Americans compared to whites, whereas male gender showed stronger association in whites (all p-interaction < 0.05). Conclusion: We identified novel correlates of kidney stone disease (triglycerides, gallstone disease) and risk factor interactions by race (age, male gender, triglycerides, gallstone disease).
KW - Epidemiology
KW - Kidney stones
KW - Risk factors
UR - http://www.scopus.com/inward/record.url?scp=77958172041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77958172041&partnerID=8YFLogxK
U2 - 10.1016/j.ypmed.2010.08.011
DO - 10.1016/j.ypmed.2010.08.011
M3 - Article
C2 - 20801154
AN - SCOPUS:77958172041
SN - 0091-7435
VL - 51
SP - 416
EP - 420
JO - Preventive Medicine
JF - Preventive Medicine
IS - 5
ER -